Invesco Health Care Fund Investor Class (GTHIX) - Health fund with $1.24 Billion in assets. The fund allocates 45.00% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is Eli Lilly and Co. at 9.65% of total assets. This is followed by Boston Scientific Corp. (5.10%) and UnitedHealth Group Inc. (3.79%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| Eli Lilly and Co. | 9.65% | - | - |
| Boston Scientific Corp. | 5.10% | - | - |
| UnitedHealth Group Inc. | 3.79% | - | - |
| McKesson Corp. | 3.43% | - | - |
| Danaher Corp. | 2.53% | - | - |
| Vertex Pharmaceuticals Inc. | 3.76% | - | - |
| Intuitive Surgical, Inc. | 5.66% | - | - |
| Merck Co., Inc. | 3.72% | - | - |
| AstraZeneca PLC, ADR | 3.80% | - | - |
| Regeneron Pharmaceuticals, Inc. | 3.56% | - | - |
| Stryker Corp. | 2.84% | - | - |
| Invesco Private Prime Fund | 3.01% | - | - |
| Cencora, Inc. | 3.12% | - | - |
| AbbVie Inc. | 3.62% | - | - |
| argenx SE, ADR | 3.66% | - | - |
| Gilead Sciences, Inc. | 3.90% | - | - |
| Tenet Healthcare Corp. | 2.39% | - | - |
| Johnson Johnson | 5.85% | - | - |
| AstraZeneca PLC | 4.18% | - | - |